Loading…
Lobbying Spend
—
Filings
50
Firms Hired
1
Active Period
2015–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Medicare reimbursement for diagnostics. HR.2369- VALID Act. Implementation of Inflation Reduction Act of 2022. Medicare Contractor Reform.
Client expense: — · Firm income: $30,000
Matched citations: HR.2369
Medicare reimbursement for diagnostics. HR.2369- VALID Act. Implementation of Inflation Reduction Act of 2022.
Client expense: — · Firm income: $30,000
Matched citations: HR.2369
Medicare reimbursement for diagnostics. HR.4128 - VALID Act. Implementation of Inflation Reduction Act of 2022.
Client expense: — · Firm income: $30,000
Matched citations: HR.4128
Medicare reimbursement for diagnostics. HR.4128 - VALID Act. Implementation of Inflation Reduction Act of 2022.
Client expense: — · Firm income: $30,000
Matched citations: HR.4128
Medicare reimbursement for diagnostics. HR.4128 - VALID Act. H.R.5376 - Inflation Reduction Act of 2022.
Client expense: — · Firm income: $30,000
Matched citations: HR.4128
Inflation Reduction Act of 2022
2022 · fourth_quarter · Firm: TODD STRATEGY GROUP
Medicare reimbursement for diagnostics. HR.4128 - VALID Act. H.R.5376 - Inflation Reduction Act of 2022.
Client expense: — · Firm income: $30,000
Matched citations: H.R.5376
Medicare reimbursement for diagnostics. HR.4128 - VALID Act.
Client expense: — · Firm income: $30,000
Matched citations: HR.4128
Medicare reimbursement for diagnostics. HR.4128 - VALID Act.
Client expense: — · Firm income: $30,000
Matched citations: HR.4128
Medicare reimbursement for diagnostics. HR.4128 - VALID Act.
Client expense: — · Firm income: $30,000
Matched citations: HR.4128
Medicare treatment of outpatient reimbursement for laboratory tests. H.R.5800: Ban Surprise Billing Act. S.3404 VALID Act of 2020.
Client expense: — · Firm income: $30,000
Matched citations: H.R.5800
Medicare treatment of outpatient reimbursement for laboratory tests. H.R.5800: Ban Surprise Billing Act. S.3404 VALID Act of 2020.
Client expense: — · Firm income: $30,000
Matched citations: S.3404
Medicare treatment of outpatient reimbursement for laboratory tests. H.R.5800: Ban Surprise Billing Act. S.3404 VALID Act of 2020.
Client expense: — · Firm income: $30,000
Matched citations: H.R.5800
Medicare treatment of outpatient reimbursement for laboratory tests. H.R.5800: Ban Surprise Billing Act. S.3404 VALID Act of 2020.
Client expense: — · Firm income: $30,000
Matched citations: S.3404
Medicare treatment of outpatient reimbursement for laboratory tests. H.R.5800: Ban Surprise Billing Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R.5800
Protecting Access to Medicare Act of 2014
2019 · fourth_quarter · Firm: TODD STRATEGY GROUP
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA regulation of laboratory developed tests (LDTs).
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4302
Protecting Access to Medicare Act of 2014
2019 · third_quarter · Firm: TODD STRATEGY GROUP
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA regulation of laboratory developed tests (LDTs).
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4302
Protecting Access to Medicare Act of 2014
2019 · second_quarter · Firm: TODD STRATEGY GROUP
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA regulation of laboratory developed tests (LDTs).
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4302
Protecting Access to Medicare Act of 2014
2019 · first_quarter · Firm: TODD STRATEGY GROUP
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA regulation of laboratory developed tests (LDTs).
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4302
Protecting Access to Medicare Act of 2014
2018 · fourth_quarter · Firm: TODD STRATEGY GROUP
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA regulation of laboratory developed tests (LDTs).
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4302
Protecting Access to Medicare Act of 2014
2018 · third_quarter · Firm: TODD STRATEGY GROUP
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA regulation of laboratory developed tests (LDTs).
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4302
Protecting Access to Medicare Act of 2014
2018 · second_quarter · Firm: TODD STRATEGY GROUP
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA regulation of laboratory developed tests (LDTs).
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4302
Protecting Access to Medicare Act of 2014
2018 · first_quarter · Firm: TODD STRATEGY GROUP
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare treatment of outpatient reimbursement for laboratory tests.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4302
Protecting Access to Medicare Act of 2014
2017 · fourth_quarter · Firm: TODD STRATEGY GROUP
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare Treatment of Outpatient Reimbursement for Laboratory tests.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4302
Protecting Access to Medicare Act of 2014
2017 · third_quarter · Firm: TODD STRATEGY GROUP
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare Treatment of Outpatient Reimbursement for Laboratory tests.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4302
Protecting Access to Medicare Act of 2014
2017 · second_quarter · Firm: TODD STRATEGY GROUP
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare Treatment of Outpatient Reimbursement for Laboratory tests.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4302
Source: Senate LDA